XOMA Corporation XOMA
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
XOMA Corporation operates as a biotech royalty aggregator, acquiring economic rights to future milestone and royalty payments from pre-commercial clinical candidates and commercial therapies licensed to pharmaceutical and biotechnology companies. This model provides sellers with non-dilutive, non-recourse funding to ad…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees13
TickerXOMA
Statistics
Market Cap$497.2M
Revenue (TTM)$52.1M
Net Income$31.7M
Net Margin60.8%
EPS$1.46
P/E26.62
P/S15.22
P/B5.91
EV/EBITDA70.27
ROE34.2%
Dividend Yield—
Price$41.74
Data: Twelve Data · Revenue = mcap / P/S